Olema Oncology, Inc. (OLMA) stock
OLMANasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.56+0.04 (+0.53%)
Close on Nov 13, 2026Market cap $661.48MP/E –Yield –
Olema Oncology enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Olema Oncology's enterprise value was $242.02M on Nov 11, 2026, against $1.62B a year earlier. Over the last 5 years it ranged from -$185.82M to $1.62B, with a median of $242.02M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $242.02M | -82.6% |
| 2025 | Dec 31, 2025 | $1.39B | +1063.9% |
| 2024 | Dec 31, 2024 | $119.19M | -75.6% |
| 2023 | Dec 29, 2023 | $489.16M | – |
| 2022 | Dec 30, 2022 | -$124.39M | -290.2% |
| 2021 | Dec 31, 2021 | $65.42M | -47.5% |
| 2020 | Dec 31, 2020 | $124.62M | – |
See a number that looks wrong?